Literature DB >> 30785714

More on Blastic Plasmacytoid Dendritic-Cell Neoplasms.

Naveen Pemmaraju1,2, Marina Konopleva1, Andrew A Lane3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30785714     DOI： 10.1056/NEJMc1814963

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Authors:  Minas P Economides; David Rizzieri; Naveen Pemmaraju
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

Review 2.  Chronic Myelomonocytic Leukemia: Hematopathology Perspective.

Authors:  Siba El Hussein; Sa A Wang; Naveen Pemmaraju; Joseph D Khoury; Sanam Loghavi
Journal:  J Immunother Precis Oncol       Date:  2021-06-18

3.  Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients.

Authors:  Kamel Laribi; Alix Baugier de Materre; Mohamad Sobh; Lorenzo Cerroni; Caterina Giovanna Valentini; Tomohiro Aoki; Ritsuro Suzuki; Kengo Takeuchi; Arthur E Frankel; Carlo Cota; David Ghez; Ronan Le Calloch; Livio Pagano; Tony Petrella
Journal:  Blood Adv       Date:  2020-10-13

4.  Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).

Authors:  Qaiser Bashir; Denái R Milton; Uday R Popat; Partow Kebriaei; Chitra Hosing; Issa F Khouri; Katayoun Rezvani; Yago Nieto; Betul Oran; Samer A Srour; Neeraj Y Saini; Amanda L Olson; Sairah Ahmed; Gheath Al-Atrash; Gabriela Rondon; Marina Y Konopleva; Richard E Champlin; Elizabeth J Shpall; Muzaffar H Qazilbash; Naveen Pemmaraju
Journal:  Bone Marrow Transplant       Date:  2021-10-11       Impact factor: 5.174

Review 5.  Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm.

Authors:  Minas P Economides; Marina Konopleva; Naveen Pemmaraju
Journal:  Ther Adv Hematol       Date:  2019-09-23

6.  Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).

Authors:  Hannah C Beird; Maliha Khan; Feng Wang; Mansour Alfayez; Tianyu Cai; Li Zhao; Joseph Khoury; P Andrew Futreal; Marina Konopleva; Naveen Pemmaraju
Journal:  Blood Cancer J       Date:  2019-12-06       Impact factor: 11.037

7.  Hyper-CVAD combined with Venetoclax for relapsed pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN): A case report and literature review.

Authors:  Dima Abla; Miguel R Abboud; Dolly Noun; Nidale Tarek; Naveen Pemmaraju
Journal:  Leuk Res Rep       Date:  2022-04-12

8.  Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm.

Authors:  Naveen Pemmaraju; Marina Konopleva
Journal:  Blood Adv       Date:  2020-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.